Holcim Ltd. (0QKY)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 66.92 |
|---|---|
| 52-week range | 60.10 – 82.46 |
| Return, 1 month / 3 months | −0.1% / −10.0% |
| Return, 1 year / 3 years | −2.3% / +158.8% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 29.7% |
| Worst drawdown (1 year) | -24.4% |
| Average daily value traded | 20.13M EUR |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Holcim Ltd. is a building materials company based in Switzerland. It makes cement, aggregates such as crushed stone and sand, and ready-mix concrete, and it also supplies related construction products and services. Its customers are mainly construction firms, builders, and infrastructure developers, and it operates across many countries around the world. The company serves both large projects and everyday building work through its network of local operations and plants.
The shares are listed on the London Stock Exchange in UK under the code 0QKY, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Holcim Ltd. (0QKY) trades on the London Stock Exchange in UK. It last closed at EUR 66.92 on 27 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 2,060 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.3% and over the last three months it fell 10.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.9% | ||
| From 52-week high | -18.2% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.0% | ||
| 6-month return | -6.2% | ||
| 12-month return, skipping the last month | -2.2% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.4% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 20.13M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.8% |
|---|---|
| 1 month | −0.1% |
| 3 months | −10.0% |
| 6 months | −6.2% |
| 1 year | −2.3% |
| 3 years | +158.8% |
| 5 years | +248.0% |
Signals
| 50-day / 200-day average | 68.02 / 71.10 |
|---|---|
| Golden / death cross (60 days) | Death, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | CHF 1.7000 |
| 16 May 2025 | CHF 1.5752 |
| 13 May 2024 | CHF 1.4227 |
| 9 May 2023 | CHF 1.2703 |
| 9 May 2022 | CHF 1.1179 |
| 7 May 2021 | CHF 1.0162 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.